John P. Iwanicki comments on a drug commercialization agreement between ImClone and Bristol-Myers in a Dow Jones Newswire article. The article appeared in SmartMoney, The Wall Street Journal and CNNMoney.
NEWS -John P. Iwanicki comments on a drug commercialization agreement between ImClone and Bristol-Myers in a Dow Jones Newswire article. The article appeared in SmartMoney, The Wall Street Journal and CNNMoney.